primary antibodies against ang Search Results


antibodies against angiotensin ii gtx37789  (GeneTex)
90
GeneTex antibodies against angiotensin ii gtx37789
Various parameters at the end of the 6 wks of follow-up evaluated preacute kidney injury (AKI) by ischemia/reperfusion: (a) urinary osmolality; (b) plasma copeptin; (c) creatinine clearance (CrCl); (d) nitrate/nitrite concentration (NO 2 /NO 3 ) in plasma; (e) nitrate/nitrite concentration (NO 2 /NO 3 ) in urine; (f) fructokinase (KHK) renal cortex expression; (g) <t>angiotensin-converting</t> enzyme 2 renal cortex expression; (h) angiotensin II renal cortex expression; (i) angiotensin II receptor type 1 (AT1-R) renal cortex expression; (j) kidney injury molecule 1 (KIM-1) renal cortex expression; (k) neutrophil gelatinase-associated lipocalin (NGAL) renal cortex expression; (l) lipid peroxidation measured in renal cortex homogenates. C: control; +W: increased water intake; +SB: sweetened beverage (SB) ad libitum; -W: fluid restriction plus hydration with tap water; -SB: fluid restriction plus hydration with SB. ∗ p < 0.05; ∗∗ p < 0.01; ∗∗∗ p < 0.001.
Antibodies Against Angiotensin Ii Gtx37789, supplied by GeneTex, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+antibodies+against+ang/pmc07661133-43-32-43?v=GeneTex
Average 90 stars, based on 1 article reviews
antibodies against angiotensin ii gtx37789 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
horseradish peroxidase (hrp)-conjugated primary antibodies against ang ii and nf  (BioFront Technologies Inc)
90
BioFront Technologies Inc horseradish peroxidase (hrp)-conjugated primary antibodies against ang ii and nf
Various parameters at the end of the 6 wks of follow-up evaluated preacute kidney injury (AKI) by ischemia/reperfusion: (a) urinary osmolality; (b) plasma copeptin; (c) creatinine clearance (CrCl); (d) nitrate/nitrite concentration (NO 2 /NO 3 ) in plasma; (e) nitrate/nitrite concentration (NO 2 /NO 3 ) in urine; (f) fructokinase (KHK) renal cortex expression; (g) <t>angiotensin-converting</t> enzyme 2 renal cortex expression; (h) angiotensin II renal cortex expression; (i) angiotensin II receptor type 1 (AT1-R) renal cortex expression; (j) kidney injury molecule 1 (KIM-1) renal cortex expression; (k) neutrophil gelatinase-associated lipocalin (NGAL) renal cortex expression; (l) lipid peroxidation measured in renal cortex homogenates. C: control; +W: increased water intake; +SB: sweetened beverage (SB) ad libitum; -W: fluid restriction plus hydration with tap water; -SB: fluid restriction plus hydration with SB. ∗ p < 0.05; ∗∗ p < 0.01; ∗∗∗ p < 0.001.
Horseradish Peroxidase (Hrp) Conjugated Primary Antibodies Against Ang Ii And Nf, supplied by BioFront Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+antibodies+against+ang/pm30712649-51-15-16?v=BioFront+Technologies+Inc
Average 90 stars, based on 1 article reviews
horseradish peroxidase (hrp)-conjugated primary antibodies against ang ii and nf - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

Image Search Results


Various parameters at the end of the 6 wks of follow-up evaluated preacute kidney injury (AKI) by ischemia/reperfusion: (a) urinary osmolality; (b) plasma copeptin; (c) creatinine clearance (CrCl); (d) nitrate/nitrite concentration (NO 2 /NO 3 ) in plasma; (e) nitrate/nitrite concentration (NO 2 /NO 3 ) in urine; (f) fructokinase (KHK) renal cortex expression; (g) angiotensin-converting enzyme 2 renal cortex expression; (h) angiotensin II renal cortex expression; (i) angiotensin II receptor type 1 (AT1-R) renal cortex expression; (j) kidney injury molecule 1 (KIM-1) renal cortex expression; (k) neutrophil gelatinase-associated lipocalin (NGAL) renal cortex expression; (l) lipid peroxidation measured in renal cortex homogenates. C: control; +W: increased water intake; +SB: sweetened beverage (SB) ad libitum; -W: fluid restriction plus hydration with tap water; -SB: fluid restriction plus hydration with SB. ∗ p < 0.05; ∗∗ p < 0.01; ∗∗∗ p < 0.001.

Journal: BioMed Research International

Article Title: Restricted Water Intake and Hydration with Fructose-Containing Beverages during Infancy Predispose to Aggravate an Acute Renal Ischemic Insult in Adolescent Rats

doi: 10.1155/2020/4281802

Figure Lengend Snippet: Various parameters at the end of the 6 wks of follow-up evaluated preacute kidney injury (AKI) by ischemia/reperfusion: (a) urinary osmolality; (b) plasma copeptin; (c) creatinine clearance (CrCl); (d) nitrate/nitrite concentration (NO 2 /NO 3 ) in plasma; (e) nitrate/nitrite concentration (NO 2 /NO 3 ) in urine; (f) fructokinase (KHK) renal cortex expression; (g) angiotensin-converting enzyme 2 renal cortex expression; (h) angiotensin II renal cortex expression; (i) angiotensin II receptor type 1 (AT1-R) renal cortex expression; (j) kidney injury molecule 1 (KIM-1) renal cortex expression; (k) neutrophil gelatinase-associated lipocalin (NGAL) renal cortex expression; (l) lipid peroxidation measured in renal cortex homogenates. C: control; +W: increased water intake; +SB: sweetened beverage (SB) ad libitum; -W: fluid restriction plus hydration with tap water; -SB: fluid restriction plus hydration with SB. ∗ p < 0.05; ∗∗ p < 0.01; ∗∗∗ p < 0.001.

Article Snippet: Antibodies against kidney injury molecule 1 (KIM-1, Cat. GTX85067, dilution 1 : 2500), fructokinase (KHK, Cat. GTX109591, dilution 1 : 5000), angiotensin-converting enzyme 2 (ACE2, Cat. GTX101395, dilution 1 : 1500), and angiotensin II (Cat. GTX37789, dilution 1 : 1000) were obtained from GeneTex, Inc., Irvine, CA, USA.

Techniques: Clinical Proteomics, Concentration Assay, Expressing, Control